The Digital Genome Market size (volume and value) and Market chain structure published by the insight partners through its high-quality database which is a valuable source of guidance and direction for companies and individual interested in the Market. Major companies with their market volumes and revenues are covered for each of the regions (north america, europe, asia pacific, middle east & africa, south & central america).
Request sample pages of this research study at – https://www.theinsightpartners.com/sample/TIPBT00002181/
The digital genome market was valued at US$ 11,065.31 million in 2019 and is projected to reach US$ 20,812.81 million 2027; it is expected to grow at a CAGR of 8.4% from 2020 to 2027.
Digital genome is a complete digital set of genetic material that present in an organism or a cell. Digital genome technology deals with genes and their functions to find the causes behind the chronic diseases and also to fix them. The technology is associated with the advancements that help to make healthcare more personal and more effective for the treatment. Moreover, the digital genome is an easier way of gathering information about the chronic disease. The technology is used by the professionals to get a closer look of genetic composed diseases, such as cancer. Digital genome acts as a supporter that enables instant access to trait combinations to solve apparently endless custom queries.
Order a copy of this research study at – https://www.theinsightpartners.com/buy/TIPBT00002181/
Based on product, the digital genome market is segmented into DNA/RNA analysis, sequencing chips, sequencing and analyzer instruments, sample prep instruments, sequencing and analysis software. The sequencing and analyzer instruments segment held the largest share of the market in 2019, owing to the advantages such as growing adoption of sequencing of analyzing instruments by pharmaceutical and biopharmaceutical companies in advanced economies. Additionally, companies are focusing on supplying superior quality instruments to research centers and pharmaceutical companies that are involved in developing therapies for genetic diseases. For instance, Thermo Fisher Scientific announced the launch of its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report workflow that delivers results economically in a single day
Based on application, the digital genome market is segmented into diagnostics, agricultural, academic research, drug discovery, personalized medicine, and other applications. In 2019, the diagnostics segment held the largest share of the global digital genome market owing to the factors such as launch of innovative diagnostic products, increasing investment in genome technologies, and expanding capabilities of the digital genome in diagnostic applications. For instance, in April 2020, Personal Genome Diagnostics, the company engaged in the development of a novel diagnostic kit for genomic profiling of different cancers, received FDA approval for its PGDx elio tissue complete test.
End User-Based Insights
Based on end user, the digital genome market is segmented into diagnostics and forensic labs, academic research institutes, hospitals, and other end user. The diagnostics and forensic labs segment held the largest share of the market in 2019, owing to increasing emphasis on adoption of digital genomes in diagnostics and forensic labs. Moreover, the recent technological advancement will help solve more cases in a shorter amount of time and will produce investigative leads for cases that would have reached dead ends and will offer lucrative opportunities during the forecast period. For instance, Illumina SBS technology, the MiSeq FGx System is the first NGS system designed specifically for forensic genomic applications.
The prominent/emerging players in the Digital Genome Market research include:
- THERMO FISHER SCIENTIFIC INC.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- NanoString Technologies, Inc.
- bioMerieux SA
- GenMark Diagnostics, Inc.
- Perkin Elmer, Inc
Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas.
Overall company/segment revenue for the year 2019, 2018, and 2017 is provided in the sub title “financial performance” (public listed companies) along with the analysis and explanation of the increase or decrease in the same due to factors such as mergers & acquisition, profit or loss in any strategic business unit (sbus) and others.
Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.
Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.
The insight partners is a one stop Market research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.
Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.
If you have any queries about this report or would like further information, please contact us:
North america: +1 646 491 9876
Asia-pacific: +91 20 6727 8686
Email: [email protected]